Bio-Techne (TECH) Tops Q3 EPS by 14c

Bio-Techne (NASDAQ: TECH) reported Q3 EPS of $2.14, $0.14 better than the analyst estimate of $2.00. Revenue for the quarter came in at $290.4 million versus the consensus estimate of $279.27 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c